To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CSDATABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
382 representative clones for gene CSDA back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DB033468 testis .a 1 to 447 2 to 448   tiling clone, capped   447/449
(99 %)
2 diff
(99.6 %id)
NM_003651.4   .a 94 to 2069 1 to 1976 exact RefSeq,   1976/1976
(100 %)
3 diff
(99.9 %id)
X72712 blood .a 123 to 1686 8 to 1571 exact     1564/1575
(99 %)
10 diff
(99.4 %id)
AK314846   .a 125 to 1455 1 to 1331 exact     1331/1331
(100 %)
2 diff
(99.9 %id)
DB460360 testis .a 125 to 589 1 to 465       465/465
(100 %)
1 diff
(99.8 %id)
DB502166 hypothalamus .a 125 to 597 1 to 473       473/473
(100 %)
1 diff
(99.8 %id)
BC008801 Lymph, Burkitt lymphoma .a 136 to 1917 1 to 1782 T75A available from MGC, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 1782/1782
(100 %)
4 diff
(99.8 %id)
M24069   .a 140 to 1691 14 to 1568 T75A R340P P341S P342S N343*     1555/1568
(99 %)
13 diff
(99.2 %id)
BC021926 Lung, large cell carcinoma .a 143 to 2054 1 to 1912 T75A available from MGC, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 1912/1912
(100 %)
4 diff
(99.8 %id)
BC015564 Muscle, rhabdomyosarcoma .a 145 to 1917 1 to 1773 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 1773/1773
(100 %)
1 diff
(100.0 %id)
X95325   .a 162 to 1542 9 to 1389 exact     1381/1392
(99 %)
9 diff
(99.4 %id)
BQ958734 epidermoid carcinoma, cell line, lung .a 443 to 1315 1 to 885       885/924
(95 %)
18 diff
(98.1 %id)
TI_151737083   .a 538 to 936 60 to 458     Submitted on the opposite strand 399/658
(60 %)
9 diff
(98.7 %id)
BF516397   .a 539 to 926 1 to 388     Submitted on the opposite strand 388/388
(100 %)
0 diff
(100 %id)
BF434967 fibrotheoma, ovary .a 546 to 1088 1 to 541     Submitted on the opposite strand 541/542
(99 %)
3 diff
(99.5 %id)
CX866594 embryonic stem .a 547 to 939 1 to 393     Submitted on the opposite strand 393/393
(100 %)
0 diff
(100 %id)
AA969622 pooled .a 556 to 963 1 to 408     Submitted on the opposite strand 408/408
(100 %)
2 diff
(99.6 %id)
AI190223 heart .a 556 to 1019 1 to 465     Submitted on the opposite strand 465/465
(100 %)
4 diff
(99.2 %id)
AI276528 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 556 to 930 1 to 377     Submitted on the opposite strand 377/377
(100 %)
2 diff
(99.5 %id)
AI377756 pooled .a 556 to 1015 1 to 461     Submitted on the opposite strand 461/461
(100 %)
4 diff
(99.2 %id)
AI376843 pooled .a 556 to 979 1 to 424     Submitted on the opposite strand 424/424
(100 %)
1 diff
(99.8 %id)
W61342 heart .a 557 to 1001 1 to 450     Submitted on the opposite strand 450/450
(100 %)
8 diff
(98.3 %id)
BF197209 brain, glioblastoma (pooled) .a 559 to 1107 1 to 548     Submitted on the opposite strand 548/548
(100 %)
3 diff
(99.5 %id)
CN421391 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 561 to 1309 1 to 749       749/749
(100 %)
2 diff
(99.8 %id)
TI_59385364   .a 579 to 1109 108 to 638       531/534
(99 %)
13 diff
(97.6 %id)
H85863 eye, retina .a 584 to 930 1 to 348     Submitted on the opposite strand 348/348
(100 %)
2 diff
(99.5 %id)
H85342 eye, retina .a 587 to 918 1 to 332     Submitted on the opposite strand 332/332
(100 %)
0 diff
(100 %id)
CN421396 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 592 to 1144 1 to 553       553/553
(100 %)
0 diff
(100 %id)
CX872654 embryonic stem .a 595 to 1304 1 to 709       709/709
(100 %)
3 diff
(99.6 %id)
AI133115 Liver .a 597 to 926 1 to 330       330/330
(100 %)
1 diff
(99.7 %id)
AA380078 skin .a 615 to 953 1 to 340       340/340
(100 %)
3 diff
(99.2 %id)
BG121134 adenocarcinoma, cell line, Liver .a 619 to 1302 1 to 672       672/924
(72 %)
15 diff
(98.4 %id)
BP331324 rectum .a 621 to 1204 1 to 584       584/584
(100 %)
0 diff
(100 %id)
BE910076 epithelioid carcinoma, Pancreas .a 627 to 1198 1 to 573       573/573
(100 %)
1 diff
(99.9 %id)
BG250062 adenocarcinoma, cell line, Liver .a 627 to 1398 8 to 777       770/933
(82 %)
26 diff
(97.3 %id)
BP235947 coronary artery .a 630 to 1207 1 to 579       579/579
(100 %)
4 diff
(99.4 %id)
CB146758 Liver .a 630 to 1196 1 to 567       567/567
(100 %)
1 diff
(99.9 %id)
BM551303 duodenal adenocarcinoma, cell line, small intestine .a 650 to 1544 1 to 906       906/1155
(78 %)
22 diff
(98.1 %id)
CB217032 normal endometrium, mid-secretory phase,cycle day 23, uterus .a 650 to 1260 1 to 611       611/611
(100 %)
0 diff
(100 %id)
BQ436176 large cell carcinoma, lung .a 676 to 1456 1 to 793       793/944
(84 %)
26 diff
(97.3 %id)
BE905964 epithelioid carcinoma, Pancreas .a 679 to 1267 1 to 589       589/589
(100 %)
0 diff
(100 %id)
CV803069 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 683 to 1343 1 to 655       655/817
(80 %)
10 diff
(98.8 %id)
BE866987 adenocarcinoma, colon .a 695 to 1309 1 to 614       614/614
(100 %)
3 diff
(99.6 %id)
TI_154137615   .a 706 to 1274 77 to 646       570/863
(66 %)
26 diff
(97.0 %id)
BQ636019 eye, retina .a 708 to 1100 1 to 393       393/393
(100 %)
3 diff
(99.3 %id)
CB143087 Liver .a 716 to 1212 1 to 497       497/497
(100 %)
1 diff
(99.8 %id)
CX757057 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 743 to 1398 1 to 652       652/820
(79 %)
14 diff
(98.3 %id)
CB070254 Pancreas, Purified pancreatic islet .a 746 to 1223 1 to 478       478/478
(100 %)
2 diff
(99.6 %id)
BQ931700 epidermoid carcinoma, cell line, lung .a 750 to 1491 1 to 750       750/910
(82 %)
17 diff
(98.2 %id)
CN421395 embryonic stem cells, DMSO-treated H9 cellline .a 764 to 1146 1 to 383       383/383
(100 %)
0 diff
(100 %id)
BP422965 small intestine .a 768 to 1210 1 to 445     Submitted on the opposite strand 445/446
(99 %)
4 diff
(99.2 %id)
BQ433724 large cell carcinoma, lung .a 772 to 1517 7 to 752   AAA   746/752
(99 %)
11 diff
(98.6 %id)
CB120222 Liver .a 772 to 935 1 to 164       164/164
(100 %)
0 diff
(100 %id)
BM452545 eye, retinoblastoma .a 786 to 1641 908 to 43   AAA Submitted on the opposite strand 866/1011
(85 %)
7 diff
(99.4 %id)
CX867007 embryonic stem .a 795 to 1566 1 to 771   fully sequenced, Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 771/771
(100 %)
1 diff
(99.9 %id)
BF969121 adrenal cortex carcinoma, cell line, adrenal gland .a 823 to 1613 1 to 790       790/927
(85 %)
23 diff
(97.6 %id)
BQ638714 eye, retina .a 845 to 1477 1 to 633       633/633
(100 %)
3 diff
(99.6 %id)
BM456442 lymph, lymphoma, cell line .a 848 to 1687 1 to 846       846/854
(99 %)
7 diff
(99.2 %id)
BU507102 leiomyosarcoma, uterus .a 850 to 1466 1 to 618       618/946
(65 %)
6 diff
(99.4 %id)
CB114969 Liver .a 884 to 1322 1 to 439       439/439
(100 %)
1 diff
(99.8 %id)
BE931314 head_neck .a 913 to 1166 274 to 12       263/283
(92 %)
14 diff
(95.1 %id)
AI064745 Liver .a 915 to 1536 620 to 1       620/620
(100 %)
10 diff
(98.4 %id)
AI110693 Liver .a 915 to 1515 618 to 19   AAA   600/603
(99 %)
2 diff
(99.7 %id)
AF063568   .a 915 to 1515 618 to 19   AAA   600/603
(99 %)
2 diff
(99.7 %id)
BG167038 hypernephroma, cell line, Kidney .a 915 to 1491 653 to 70     Submitted on the opposite strand 587/653
(89 %)
18 diff
(97.3 %id)
BQ955024 epidermoid carcinoma, cell line, lung .a 932 to 1805 1 to 875       875/923
(94 %)
18 diff
(98.1 %id)
BP429963   .a 935 to 1152 11 to 229       219/229
(95 %)
10 diff
(95.7 %id)
AI207399 Liver .a 945 to 1517 593 to 20   AAA   574/574
(100 %)
3 diff
(99.5 %id)
BE747225 adenocarcinoma cell line, ovary .a 947 to 1752 1 to 797       797/971
(82 %)
20 diff
(98.0 %id)
BG390215 embryonal carcinoma, cell line, testis .a 963 to 1601 1 to 639       639/639
(100 %)
0 diff
(100 %id)
BU619473 Cell Line, Chondrosarcoma .a 972 to 1649 678 to 1       678/678
(100 %)
4 diff
(99.5 %id)
AA481696 ovarian tumor, ovary .a 991 to 1420 1 to 427   fully sequenced,   427/427
(100 %)
8 diff
(98.2 %id)
CA453944   .a 995 to 1863 1 to 875       875/875
(100 %)
8 diff
(99.1 %id)
CN421390 embryonic stem cells, cell lines H1, H7, andH9 .a 1011 to 1463 1 to 453       453/453
(100 %)
3 diff
(99.4 %id)
BF851416 lung_normal .a 1030 to 1435 418 to 13     Submitted on the opposite strand 406/418
(97 %)
0 diff
(100 %id)
AJ711267 heart .a 1035 to 1491 469 to 13     Submitted on the opposite strand 457/469
(97 %)
0 diff
(100 %id)
BF970950 adrenal cortex carcinoma, cell line, adrenal gland .a 1041 to 1791 1 to 754       754/755
(99 %)
10 diff
(98.7 %id)
H26227 breast .a 1043 to 1365 323 to 1     Submitted on the opposite strand 323/323
(100 %)
2 diff
(99.4 %id)
H42965 breast .a 1043 to 1309 267 to 1     Submitted on the opposite strand 267/267
(100 %)
1 diff
(99.7 %id)
W52519 senescent fibroblast .a 1044 to 1527 488 to 1     Submitted on the opposite strand 488/596
(81 %)
6 diff
(99.0 %id)
BF083766 colon .a 1052 to 1581 530 to 1       530/530
(100 %)
7 diff
(98.7 %id)
AI758803 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 1052 to 1641 588 to 1       588/588
(100 %)
5 diff
(99.2 %id)
CD617339   .a 1062 to 1489 433 to 1       433/433
(100 %)
11 diff
(97.5 %id)
EL954947 eyeball .a 1063 to 1468 1 to 407       407/407
(100 %)
6 diff
(98.6 %id)
EL949986 eyeball .a 1093 to 1710 8 to 625       618/625
(98 %)
8 diff
(98.8 %id)
AA481461 ovarian tumor, ovary .a 1373 to 1928 557 to 1   fully sequenced,   557/557
(100 %)
2 diff
(99.7 %id)
CX866922 embryonic stem .a 1536 to 2054 550 to 32   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 519/519
(100 %)
5 diff
(99.1 %id)
CB069745 Pancreas, Purified pancreatic islet .a 1678 to 2055 379 to 2   tiling clone,   378/379
(99 %)
0 diff
(100 %id)
CN421400 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 1 to 788 1 to 788   tiling clone,   788/788
(100 %)
1 diff
(99.9 %id)
BX414696 thymus .b 478 to 1383 903 to 1   tiling clone,   903/903
(100 %)
11 diff
(98.8 %id)
BG928091 cartilage .b 699 to 1264 78 to 643   tiling clone,   566/575
(98 %)
9 diff
(98.5 %id)
AU117252 whole embryo, mainly head .c 1 to 733 2 to 735   tiling clone, capped   734/739
(99 %)
9 diff
(98.8 %id)
NM_001145426.1   .c 2 to 1770 1 to 1769 exact RefSeq,   1769/1769
(100 %)
3 diff
(99.9 %id)
BM847177 myeloma .c 3 to 445 1 to 443       443/443
(100 %)
3 diff
(99.4 %id)
BM847778 myeloma .c 4 to 529 1 to 525       525/525
(100 %)
2 diff
(99.7 %id)
AU121196 whole embryo, mainly body .c 34 to 702 2 to 674   capped   673/680
(98 %)
14 diff
(98.0 %id)
BM843682 lymph node, stomach .c 35 to 559 1 to 525       525/525
(100 %)
3 diff
(99.5 %id)
BG332382 large cell carcinoma, lung .c 41 to 784 1 to 740       742/909
(81 %)
34 diff
(96.3 %id)
BM720594 eye, fetal eye .c 41 to 672 1 to 633       633/633
(100 %)
5 diff
(99.3 %id)
BC009744 Ovary, adenocarcinoma .c 49 to 1750 1 to 1703 T75A V135L tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 1703/1703
(100 %)
6 diff
(99.7 %id)
BM722612 eye, fetal eye .c 54 to 471 1 to 418     Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 418/418
(100 %)
4 diff
(99.1 %id)
BC015913 Kidney, renal cell adenocarcinoma .c 60 to 1618 1 to 1559 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 1559/1559
(100 %)
2 diff
(99.9 %id)
DA700310   .c 75 to 363 2 to 290   capped   289/289
(100 %)
0 diff
(100 %id)
BF590681 colon, colon tumor, RER+ .c 76 to 314 239 to 1       239/239
(100 %)
0 diff
(100 %id)
DB455186 testis .c 172 to 661 1 to 491       491/491
(100 %)
3 diff
(99.4 %id)
DB453339 testis .c 174 to 685 1 to 512       512/512
(100 %)
4 diff
(99.3 %id)
DB460574 testis .c 189 to 668 1 to 480       480/480
(100 %)
0 diff
(100 %id)
CK823572 Islets of Langerhans, Pancreas .c 206 to 260 55 to 1       55/55
(100 %)
0 diff
(100 %id)
DB457831 testis .c 219 to 713 1 to 495       495/495
(100 %)
3 diff
(99.4 %id)
AI111181 Liver .c 454 to 1237 1 to 779       779/780
(99 %)
22 diff
(97.2 %id)
AI174770 Liver .c 454 to 1216 1 to 763   AAA   763/763
(100 %)
6 diff
(99.3 %id)
AI337970 uterus .c 464 to 870 1 to 407     Submitted on the opposite strand 407/407
(100 %)
0 diff
(100 %id)
AI360980 brain, glioblastoma (pooled) .c 464 to 877 1 to 414     Submitted on the opposite strand 414/414
(100 %)
0 diff
(100 %id)
AI494536 B-cell, chronic lymphotic leukemia .c 464 to 1238 1 to 771     Submitted on the opposite strand 771/777
(99 %)
16 diff
(98.0 %id)
AI475750 B-cell, chronic lymphotic leukemia .c 464 to 957 1 to 494     Submitted on the opposite strand 494/494
(100 %)
1 diff
(99.8 %id)
AI693008 pooled .c 464 to 915 1 to 452     Submitted on the opposite strand 452/452
(100 %)
1 diff
(99.8 %id)
AW026954 thymus, pooled .c 464 to 904 1 to 441     Submitted on the opposite strand 441/441
(100 %)
0 diff
(100 %id)
BF195718 fibrotheoma, ovary .c 464 to 1078 1 to 615     Submitted on the opposite strand 615/615
(100 %)
4 diff
(99.4 %id)
AA877155 Kidney .c 467 to 959 1 to 493     Submitted on the opposite strand 493/493
(100 %)
1 diff
(99.8 %id)
CN421392 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 476 to 1220 1 to 745       745/755
(98 %)
2 diff
(99.8 %id)
BM457219 embryonal carcinoma, cell line, testis .c 477 to 1191 31 to 748       718/1040
(69 %)
17 diff
(98.4 %id)
AA514335 colon .c 484 to 1010 1 to 527     Submitted on the opposite strand 527/527
(100 %)
2 diff
(99.7 %id)
CA453711 mixed (pool of 40 RNAs) .c 484 to 1095 1 to 612       612/884
(69 %)
6 diff
(99.4 %id)
AA455300 ovarian tumor, ovary .c 487 to 898 1 to 412     Submitted on the opposite strand 412/412
(100 %)
0 diff
(100 %id)
C03891 heart .c 489 to 758 1 to 270       270/270
(100 %)
0 diff
(100 %id)
AA382137 testis .c 495 to 703 1 to 209       209/213
(98 %)
0 diff
(100 %id)
AA340286 Liver .c 497 to 733 1 to 237       237/237
(100 %)
0 diff
(100 %id)
H25849 breast .c 511 to 736 1 to 226     Submitted on the opposite strand 226/226
(100 %)
0 diff
(100 %id)
CV807133 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 528 to 1191 1 to 666       666/899
(74 %)
11 diff
(98.8 %id)
AI760014 B-cell, chronic lymphotic leukemia .c 530 to 1217 1 to 688     Submitted on the opposite strand 688/688
(100 %)
7 diff
(99.0 %id)
BM848537 myeloma .c 542 to 1030 1 to 490       490/490
(100 %)
1 diff
(99.8 %id)
AA383380 testis .c 544 to 701 1 to 158       158/161
(98 %)
5 diff
(96.9 %id)
TI_151794812   .c 549 to 1393 109 to 965       857/858
(99 %)
26 diff
(97.0 %id)
AA345996 NULL, omentum .c 553 to 812 1 to 260       260/260
(100 %)
0 diff
(100 %id)
ES314566 occipital scalp hair, skin .c 562 to 685 1 to 124       124/124
(100 %)
0 diff
(100 %id)
AA111995 muscle, skeletal muscle .c 573 to 825 1 to 253       253/253
(100 %)
5 diff
(98.1 %id)
AA176737 muscle, skeletal muscle .c 617 to 857 1 to 242       242/242
(100 %)
2 diff
(99.2 %id)
BG284902 adenocarcinoma, cell line, Prostate .c 617 to 1103 1 to 487       487/487
(100 %)
2 diff
(99.6 %id)
BG697269 skin .c 618 to 1422 1 to 807       807/808
(99 %)
9 diff
(98.9 %id)
BM697141 eye, lens .c 624 to 1277 1 to 654     Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 654/654
(100 %)
0 diff
(100 %id)
BM705789 eye, lens .c 629 to 1029 1 to 401     Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 401/401
(100 %)
0 diff
(100 %id)
CD676122 eye, lens .c 630 to 1237 606 to 3     Submitted on the opposite strand 604/606
(99 %)
0 diff
(100 %id)
AA378196 synovial membrane .c 658 to 949 1 to 292       292/292
(100 %)
0 diff
(100 %id)
AW954495   .c 659 to 1285 1 to 627       627/628
(99 %)
5 diff
(99.3 %id)
AW954500   .c 659 to 1291 1 to 634       634/638
(99 %)
5 diff
(99.3 %id)
BP315922 pericardium .c 668 to 1247 1 to 582       582/582
(100 %)
5 diff
(99.2 %id)
BU679380 lung, Primary Lung Epithelial Cells .c 679 to 1218 556 to 17   AAA   540/547
(98 %)
0 diff
(100 %id)
BF868962 lung_tumor .c 729 to 1240 1 to 512       512/512
(100 %)
5 diff
(99.1 %id)
BF795153 lymph, lymphoma, cell line .c 818 to 1627 816 to 1     Submitted on the opposite strand 816/907
(89 %)
19 diff
(98.0 %id)
TI_149295286   .c 822 to 1618 872 to 79   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 794/936
(84 %)
13 diff
(98.7 %id)
BG251602 adenocarcinoma, cell line, Liver .c 827 to 1619 1 to 790       790/800
(98 %)
12 diff
(98.5 %id)
AA641147 invasive tumor (cell line), Prostate .c 833 to 1589 753 to 1       753/767
(98 %)
17 diff
(97.8 %id)
CR624602 HeLa cells Cot 25-normalized .c 843 to 1761 1 to 919   tiling clone,   919/919
(100 %)
0 diff
(100 %id)
AL556190 placenta .c 843 to 1756 1 to 914   fully sequenced,   914/914
(100 %)
2 diff
(99.8 %id)
BU958820 mixed (pool of 40 RNAs) .c 843 to 1588 1 to 752       752/756
(99 %)
24 diff
(96.9 %id)
BE545337 cervical carcinoma cell line, cervix .c 851 to 1562 1 to 706       706/874
(80 %)
17 diff
(98.1 %id)
CD366370 Alveolar Macrophage, lung .c 852 to 1618 778 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 760/760
(100 %)
12 diff
(98.5 %id)
BI256941 cervical carcinoma cell line, cervix .c 854 to 1627 780 to 1     Submitted on the opposite strand 780/991
(78 %)
19 diff
(98.1 %id)
BI259754 cervical carcinoma cell line, cervix .c 855 to 1618 789 to 23   AAA Submitted on the opposite strand 767/767
(100 %)
4 diff
(99.5 %id)
BG941524 blood .c 857 to 1160 1 to 304       304/304
(100 %)
0 diff
(100 %id)
BE877045 large cell carcinoma, undifferentiated, lung .c 859 to 1460 1 to 602       602/602
(100 %)
2 diff
(99.7 %id)
BF340722 brain, glioblastoma with EGFR amplification .c 896 to 1667 1 to 769       769/770
(99 %)
18 diff
(97.7 %id)
AW469333 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .c 905 to 1333 429 to 1       429/429
(100 %)
0 diff
(100 %id)
BQ436054 epithelioid carcinoma, Pancreas .c 905 to 1618 759 to 36   AAA Submitted on the opposite strand 724/872
(83 %)
18 diff
(98.0 %id)
W72165 heart .c 915 to 1367 1 to 448   fully sequenced,   448/448
(100 %)
1 diff
(99.8 %id)
BQ231433 large cell carcinoma, lung .c 916 to 1755 878 to 30   AAA Submitted on the opposite strand 849/851
(99 %)
39 diff
(95.5 %id)
BQ420606 large cell carcinoma, lung .c 918 to 1530 141 to 759       619/1021
(60 %)
31 diff
(97.0 %id)
CF243060 Brain glioblastoma .c 918 to 1756 848 to 6     Submitted on the opposite strand 843/848
(99 %)
10 diff
(98.9 %id)
TI_149301563   .c 920 to 1752 910 to 87   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 824/935
(88 %)
12 diff
(98.8 %id)
TI_154091522   .c 920 to 1755 925 to 100   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 826/931
(88 %)
18 diff
(98.1 %id)
BQ424658 eye, retinoblastoma .c 923 to 1757 883 to 41   AAA Submitted on the opposite strand 843/876
(96 %)
23 diff
(97.4 %id)
BM705000 eye, lens .c 927 to 1461 1 to 535     Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 535/544
(98 %)
1 diff
(99.9 %id)
AI064935 Liver .c 939 to 1620 679 to 1       679/679
(100 %)
9 diff
(98.7 %id)
BI768970 pooled lung and spleen .c 939 to 1633 1 to 695   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 695/695
(100 %)
5 diff
(99.3 %id)
BU193861 leiomyosarcoma, uterus .c 941 to 1756 825 to 5     Submitted on the opposite strand 821/915
(89 %)
15 diff
(98.4 %id)
BM985388 lung .c 941 to 1618 696 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 678/678
(100 %)
5 diff
(99.3 %id)
N35942 melanocyte .c 942 to 1042 101 to 1     Submitted on the opposite strand 101/101
(100 %)
0 diff
(100 %id)
BU630866 cell lines, Chondrosarcoma .c 942 to 1618 695 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 677/677
(100 %)
1 diff
(99.9 %id)
DR421795 eye, Pterygium .c 945 to 1614 670 to 1     Submitted on the opposite strand 670/670
(100 %)
1 diff
(99.9 %id)
BU633675 cell lines, Chondrosarcoma .c 954 to 1618 684 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 666/666
(100 %)
2 diff
(99.7 %id)
BE780697 eye, retinoblastoma .c 957 to 1612 1 to 657       657/657
(100 %)
4 diff
(99.4 %id)
BI825756 brain, medulla .c 959 to 1755 1 to 796   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 796/796
(100 %)
7 diff
(99.2 %id)
CB132889 Liver .c 959 to 1558 1 to 600       600/600
(100 %)
0 diff
(100 %id)
CB146760 Liver .c 970 to 1663 1 to 694       694/694
(100 %)
0 diff
(100 %id)
AA195822 muscle, skeletal muscle .c 972 to 1258 1 to 286   fully sequenced,   286/286
(100 %)
2 diff
(99.4 %id)
AA195826 muscle, skeletal muscle .c 972 to 1221 1 to 245   fully sequenced,   245/245
(100 %)
0 diff
(100 %id)
CX757478 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 972 to 1756 778 to 3       776/837
(92 %)
14 diff
(98.4 %id)
AW665530 pooled .c 982 to 1618 637 to 1       637/637
(100 %)
9 diff
(98.6 %id)
TI_151718140   .c 992 to 1618 770 to 144   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 627/923
(67 %)
16 diff
(98.3 %id)
BM712310 eye, lens .c 994 to 1460 1 to 467       467/467
(100 %)
1 diff
(99.8 %id)
BI029784 marrow .c 1000 to 1457 456 to 1       456/456
(100 %)
4 diff
(99.2 %id)
CD677015 eye, Trabecular meshwork .c 1001 to 1517 1 to 514       514/514
(100 %)
3 diff
(99.5 %id)
BQ025451 placenta .c 1002 to 1618 635 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 617/617
(100 %)
0 diff
(100 %id)
BQ335389 marrow .c 1004 to 1457 451 to 1       451/451
(100 %)
3 diff
(99.4 %id)
CX759570 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 1005 to 1758 754 to 2       753/754
(99 %)
1 diff
(99.9 %id)
BU630832 cell lines, Chondrosarcoma .c 1016 to 1618 622 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 604/604
(100 %)
3 diff
(99.6 %id)
BM701665 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 1024 to 1530 1 to 507   fully sequenced,   507/507
(100 %)
1 diff
(99.9 %id)
AV722048 hypothalamus .c 1025 to 1620 1 to 596       596/627
(95 %)
3 diff
(99.6 %id)
AA446787   .c 1025 to 1445 1 to 421   fully sequenced, Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 421/421
(100 %)
4 diff
(99.1 %id)
BQ014556 Chondrosarcoma, Left Pubic Bone .c 1031 to 1755 743 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 725/725
(100 %)
1 diff
(99.9 %id)
CA427824 Bone, Subchondral Bone .c 1035 to 1755 740 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 722/722
(100 %)
2 diff
(99.8 %id)
BM979988 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 1037 to 1752 731 to 17   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 715/715
(100 %)
2 diff
(99.8 %id)
CA434393 lung, Metastatic Chondrosarcoma .c 1042 to 1755 732 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 714/714
(100 %)
3 diff
(99.6 %id)
CX759923 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 1050 to 1755 722 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 704/742
(94 %)
8 diff
(99.0 %id)
CX871267 embryonic stem .c 1057 to 1757 726 to 26   AAA Submitted on the opposite strand 701/703
(99 %)
0 diff
(100 %id)
DR763576 embryonic stem .c 1057 to 1755 726 to 28   AAA Submitted on the opposite strand 699/699
(100 %)
1 diff
(99.9 %id)
CD677099 eye, Trabecular meshwork .c 1066 to 1618 1 to 553   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 553/553
(100 %)
1 diff
(99.9 %id)
CD677842 eye, Trabecular meshwork .c 1066 to 1618 1 to 553   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 553/553
(100 %)
0 diff
(100 %id)
TI_59393491   .c 1066 to 1618 115 to 668   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 554/554
(100 %)
3 diff
(99.5 %id)
BM015265 breast, mammary adenocarcinoma, cell line .c 1069 to 1619 1 to 552   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 552/553
(99 %)
4 diff
(99.3 %id)
CX871466 embryonic stem .c 1072 to 1756 690 to 6     Submitted on the opposite strand 685/690
(99 %)
0 diff
(100 %id)
CX754835 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 1072 to 1755 698 to 15   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 684/684
(100 %)
1 diff
(99.9 %id)
CD677561 eye, Trabecular meshwork .c 1077 to 1714 1 to 638       638/638
(100 %)
2 diff
(99.7 %id)
BQ014819 Chondrosarcoma, Left Pubic Bone .c 1079 to 1618 559 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 541/541
(100 %)
3 diff
(99.5 %id)
TI_154103749   .c 1090 to 1755 750 to 94   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 657/780
(84 %)
20 diff
(97.5 %id)
DB331002.
matches multiple genes
skeletal muscle .c 1095 to 1618 525 to 1     also hits gene ACTC1 525/525
(100 %)
3 diff
(99.5 %id)
BM722784 eye, fetal eye .c 1095 to 1722 1 to 628       628/628
(100 %)
0 diff
(100 %id)
AA465019 ovarian tumor, ovary .c 1096 to 1622 534 to 7     Submitted on the opposite strand 528/534
(98 %)
0 diff
(100 %id)
BM714179 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 1098 to 1279 1 to 182       182/182
(100 %)
0 diff
(100 %id)
W69811 heart .c 1106 to 1408 1 to 303   fully sequenced,   303/303
(100 %)
1 diff
(99.7 %id)
BU602456 mixed (pool of 40 RNAs) .c 1109 to 1755 1 to 649       649/656
(98 %)
5 diff
(99.3 %id)
BP389361 pancreatic islet .c 1113 to 1622 1 to 510     Submitted on the opposite strand 510/510
(100 %)
1 diff
(99.9 %id)
CX166827 human embryonic stem cells differentiated toan early endodermal cell type .c 1115 to 1755 663 to 23   AAA Submitted on the opposite strand 641/641
(100 %)
3 diff
(99.6 %id)
AI127381 heart .c 1120 to 1618 499 to 1       499/499
(100 %)
0 diff
(100 %id)
BQ016627 lung, Metastatic Chondrosarcoma .c 1125 to 1755 649 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 631/631
(100 %)
4 diff
(99.4 %id)
BM992589 lung, Metastatic Chondrosarcoma .c 1126 to 1755 648 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 630/630
(100 %)
2 diff
(99.7 %id)
BU738720 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 1126 to 1534 427 to 19   fully sequenced, AAA   409/409
(100 %)
1 diff
(99.8 %id)
BU629152 cell lines, Chondrosarcoma .c 1128 to 1757 647 to 17   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 631/631
(100 %)
2 diff
(99.7 %id)
AI150246   .c 1137 to 1621 485 to 1       485/485
(100 %)
1 diff
(99.8 %id)
CR744585 heart .c 1145 to 1618 1 to 474   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 474/474
(100 %)
1 diff
(99.8 %id)
AA195977 muscle, skeletal muscle .c 1160 to 1620 453 to 1   fully sequenced,   453/453
(100 %)
5 diff
(98.9 %id)
TI_154182690   .c 1160 to 1755 78 to 674       597/874
(68 %)
4 diff
(99.6 %id)
W60042 heart .c 1171 to 1621 451 to 1     Submitted on the opposite strand 451/451
(100 %)
2 diff
(99.6 %id)
CD674275 eye, lens .c 1178 to 1618 456 to 16   AAA Submitted on the opposite strand 441/441
(100 %)
0 diff
(100 %id)
AI493237 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .c 1188 to 1618 431 to 1       431/431
(100 %)
0 diff
(100 %id)
AI809631 pooled .c 1193 to 1636 447 to 3       445/447
(99 %)
0 diff
(100 %id)
AW189293 serous papillary carcinoma, high grade, 2pooled tumors, uterus .c 1193 to 1620 428 to 1       428/428
(100 %)
0 diff
(100 %id)
BG212734   .c 1195 to 1750 572 to 18   AAA Submitted on the opposite strand 555/555
(100 %)
3 diff
(99.5 %id)
AI911093 pooled .c 1195 to 1756 564 to 4       561/564
(99 %)
0 diff
(100 %id)
CN421399 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 1198 to 1722 525 to 1     Submitted on the opposite strand 525/525
(100 %)
1 diff
(99.9 %id)
W60766 heart .c 1200 to 1616 1 to 416   fully sequenced,   416/416
(100 %)
2 diff
(99.6 %id)
AA173887   .c 1202 to 1659 1 to 461       461/461
(100 %)
5 diff
(99.0 %id)
AA085931 muscle, skeletal muscle .c 1204 to 1589 389 to 1       389/389
(100 %)
3 diff
(99.3 %id)
CD677935 eye, Trabecular meshwork .c 1209 to 1691 1 to 483       483/483
(100 %)
2 diff
(99.6 %id)
AV703416 adrenal gland .c 1216 to 1618 1 to 403   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 403/403
(100 %)
0 diff
(100 %id)
AA176478 muscle, skeletal muscle .c 1217 to 1590 374 to 1       374/374
(100 %)
0 diff
(100 %id)
BM679255 eye, fetal eye .c 1219 to 1755 555 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 537/537
(100 %)
7 diff
(98.7 %id)
AI752985 bone marrow stroma .c 1224 to 1618 413 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 395/395
(100 %)
0 diff
(100 %id)
CD675900 eye, lens .c 1226 to 1755 1 to 532   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 532/532
(100 %)
3 diff
(99.5 %id)
AA195973 muscle, skeletal muscle .c 1228 to 1618 388 to 1   fully sequenced,   388/388
(100 %)
1 diff
(99.8 %id)
BM687804 eye, Retina Foveal and Macular .c 1232 to 1618 1 to 387   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 387/387
(100 %)
0 diff
(100 %id)
AA609157   .c 1238 to 1621 384 to 1       384/384
(100 %)
0 diff
(100 %id)
AI802439   .c 1243 to 1756 518 to 5       514/518
(99 %)
0 diff
(100 %id)
BM888376 eye .c 1252 to 1750 510 to 11   AAA Submitted on the opposite strand 500/500
(100 %)
2 diff
(99.6 %id)
BP394036 pancreatic islet .c 1259 to 1759 1 to 501     Submitted on the opposite strand 501/501
(100 %)
1 diff
(99.9 %id)
BU734988 eye, lens .c 1261 to 1755 513 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 495/495
(100 %)
1 diff
(99.8 %id)
AA151250 uterus .c 1265 to 1423 1 to 166   fully sequenced,   166/166
(100 %)
0 diff
(100 %id)
AI004865   .c 1272 to 1621 350 to 1       350/350
(100 %)
0 diff
(100 %id)
DB524344 testis .c 1275 to 1757 1 to 483     Submitted on the opposite strand 483/483
(100 %)
1 diff
(99.8 %id)
DB354997 whole embryo, mainly head .c 1278 to 1755 478 to 1       478/478
(100 %)
6 diff
(98.8 %id)
DB523323 testis .c 1283 to 1759 1 to 477     Submitted on the opposite strand 477/478
(99 %)
2 diff
(99.6 %id)
DB573372 hypothalamus .c 1288 to 1759 1 to 473     Submitted on the opposite strand 473/473
(100 %)
2 diff
(99.6 %id)
BM690059 eye, Retina Foveal and Macular .c 1289 to 1618 1 to 330   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 330/330
(100 %)
0 diff
(100 %id)
DB518818 testis .c 1291 to 1753 1 to 463     Submitted on the opposite strand 463/465
(99 %)
2 diff
(99.6 %id)
DB528035 testis .c 1291 to 1755 1 to 466   AAA Submitted on the opposite strand 466/466
(100 %)
2 diff
(99.6 %id)
AW303489 pooled .c 1294 to 1756 466 to 4       463/466
(99 %)
0 diff
(100 %id)
AL578497 placenta .c 1307 to 1719 415 to 1   fully sequenced,   415/415
(100 %)
4 diff
(99.1 %id)
CA445958 Chondrosarcoma, Left Pelvis .c 1311 to 1755 462 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 444/444
(100 %)
2 diff
(99.6 %id)
DB523481 testis .c 1321 to 1755 1 to 435     Submitted on the opposite strand 435/435
(100 %)
1 diff
(99.8 %id)
F26845 pectoral muscle (after mastectomy) .c 1321 to 1546 1 to 226       226/226
(100 %)
0 diff
(100 %id)
W74589 heart .c 1337 to 1618 284 to 1   fully sequenced,   284/284
(100 %)
1 diff
(99.7 %id)
AI379686 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 1344 to 1618 275 to 1       275/275
(100 %)
0 diff
(100 %id)
W69772 heart .c 1378 to 1619 249 to 1   fully sequenced,   249/249
(100 %)
0 diff
(100 %id)
BM668093 eye, lens .c 1380 to 1755 395 to 20   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 376/376
(100 %)
11 diff
(97.1 %id)
AA151251 uterus .c 1393 to 1765 373 to 1   fully sequenced,   373/373
(100 %)
0 diff
(100 %id)
AA432101   .c 1415 to 1755 357 to 23   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 335/335
(100 %)
2 diff
(99.5 %id)
BM661778 eye, Retina Foveal and Macular .c 1420 to 1587 168 to 1   fully sequenced, Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 168/168
(100 %)
0 diff
(100 %id)
T36062 testis .c 1426 to 1618 1 to 193       193/193
(100 %)
0 diff
(100 %id)
AI056564 B-cell, chronic lymphotic leukemia .c 1433 to 1755 336 to 14   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 323/323
(100 %)
0 diff
(100 %id)
W60705 heart .c 1447 to 1619 173 to 1   fully sequenced,   173/173
(100 %)
0 diff
(100 %id)
AW516437 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 1447 to 1766 320 to 1       320/320
(100 %)
0 diff
(100 %id)
AA292438 ovarian tumor, ovary .c 1449 to 1618 170 to 1       170/170
(100 %)
0 diff
(100 %id)
CB851955 Human Lung Epithelial cells, lung .c 1450 to 1632 1 to 183   AAA Submitted on the opposite strand 183/212
(86 %)
9 diff
(95.8 %id)
H97248 melanocyte .c 1510 to 1729 220 to 1       220/220
(100 %)
0 diff
(100 %id)
AA147918   .c 1594 to 1750 194 to 38   AAA Submitted on the opposite strand 157/157
(100 %)
0 diff
(100 %id)
BU734578 eye, lens .c 1620 to 1755 154 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 136/136
(100 %)
1 diff
(99.3 %id)
AI763104 B-cell, chronic lymphotic leukemia .c 1652 to 1755 115 to 12   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 104/104
(100 %)
0 diff
(100 %id)
FN158438 breast carcinoma .d 1 to 114 107 to 1   tiling clone, Submitted on the opposite strand 107/107
(100 %)
8 diff
(92.6 %id)
AA075594   .d 107 to 549 1 to 449   tiling clone,   447/449
(99 %)
9 diff
(98.0 %id)
AA075341   .d 578 to 1115 540 to 1   tiling clone,   540/540
(100 %)
13 diff
(97.6 %id)
BP244811 Kidney .e 1 to 584 1 to 583   tiling clone,   583/583
(100 %)
2 diff
(99.7 %id)
BE513481 Burkitt lymphoma, lymph .e 138 to 792 1 to 654   tiling clone,   654/726
(90 %)
22 diff
(97.0 %id)
BG254070 adenocarcinoma, cell line, Prostate .f 1 to 817 1 to 818 G107D P108L P109L R110A P111H ... tiling clone,   818/818
(100 %)
28 diff
(96.6 %id)
AI133674 Liver .f 152 to 617 486 to 21   AAA   466/466
(100 %)
2 diff
(99.6 %id)
AI904064 breast .f 230 to 620 438 to 48   tiling clone,   391/438
(89 %)
0 diff
(100 %id)
AW369654 breast .f 230 to 662 434 to 3   tiling clone,   432/434
(99 %)
1 diff
(99.8 %id)
CB159096 Liver .g 1 to 526 1 to 525   tiling clone,   525/525
(100 %)
1 diff
(99.9 %id)
BX645686   .g 244 to 922 1 to 680   tiling clone,   680/680
(100 %)
2 diff
(99.8 %id)
AL698250 human skeletal muscle .g 387 to 968 1 to 577       577/577
(100 %)
4 diff
(99.4 %id)
BX491622   .g 477 to 947 1 to 470       470/470
(100 %)
2 diff
(99.6 %id)
BX499718 Liver .g 624 to 1349 1 to 727       727/727
(100 %)
2 diff
(99.8 %id)
DB225227 trachea .g 846 to 1420 2 to 576   tiling clone, capped   575/575
(100 %)
0 diff
(100 %id)
DB089259 testis .g 1031 to 1579 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
BX641551   .g 1298 to 1742 1 to 445   tiling clone,   445/445
(100 %)
0 diff
(100 %id)
DB013345 esophageal, tumor tissue .g 1598 to 2176 2 to 580   tiling clone, capped   579/579
(100 %)
0 diff
(100 %id)
BX492064   .g 1900 to 2419 1 to 520   tiling clone,   520/520
(100 %)
0 diff
(100 %id)
BF848289 lung_normal .g 2413 to 2820 14 to 421   tiling clone,   408/421
(96 %)
6 diff
(98.6 %id)
N28474 melanocyte .g 2548 to 2934 1 to 393       393/393
(100 %)
10 diff
(97.5 %id)
N28499 melanocyte .g 2567 to 2935 1 to 373   tiling clone,   373/373
(100 %)
4 diff
(99.0 %id)
BQ925225 sciatic nerve .g 2680 to 3594 1 to 915 E120X N142H E164G P172H T174P ... tiling clone,   915/921
(99 %)
24 diff
(97.4 %id)
H99755 melanocyte .g 3527 to 3935 413 to 1   tiling clone,   413/414
(99 %)
7 diff
(98.4 %id)
H99773 melanocyte .g 3527 to 3935 412 to 1   tiling clone,   412/417
(98 %)
3 diff
(99.3 %id)
DB335386 esophageal, tumor tissue .g 3828 to 4068 241 to 1   tiling clone,   241/241
(100 %)
1 diff
(99.6 %id)
CU455143 epidermis .h 1 to 717 716 to 1 E146G tiling clone, Submitted on the opposite strand 716/716
(100 %)
7 diff
(99.1 %id)
DB458850 testis .i 1 to 452 1 to 452   tiling clone,   452/452
(100 %)
1 diff
(99.8 %id)
BP398128 pancreatic islet .i 296 to 733 1 to 438   tiling clone, Submitted on the opposite strand 438/438
(100 %)
0 diff
(100 %id)
AI762961 B-cell, chronic lymphotic leukemia .i 333 to 720 1 to 388     Submitted on the opposite strand 388/388
(100 %)
1 diff
(99.8 %id)
AI141212 lung .j 1 to 448 1 to 448 V139X tiling clone, Submitted on the opposite strand 448/449
(99 %)
2 diff
(99.6 %id)
CD172385 White Matter .k 1 to 790 1 to 793 exact tiling clone,   793/859
(92 %)
7 diff
(99.2 %id)
DB110585 thymus .l 1 to 599 2 to 601   tiling clone, capped   600/600
(100 %)
2 diff
(99.7 %id)
BU665383 blood .l 633 to 1309 11 to 687   tiling clone,   677/687
(98 %)
6 diff
(99.2 %id)
DB343294 thymus .l 1011 to 1538 529 to 1   tiling clone,   529/529
(100 %)
2 diff
(99.7 %id)
BG739968 skin .m 1 to 701 1 to 701 R52V P53L P54L N55T A56L ... tiling clone,   701/705
(99 %)
17 diff
(97.6 %id)
BE935120 marrow .n 1 to 181 182 to 2 K2S tiling clone,   181/182
(99 %)
2 diff
(99.0 %id)
BE935142 marrow .n 1 to 181 182 to 2 K2S     181/182
(99 %)
2 diff
(99.0 %id)
AB209896 aorta endothelial cell .o 1 to 6393 1 to 6394 exact tiling clone,   6394/6394
(100 %)
2 diff
(100.0 %id)
AI760568 B-cell, chronic lymphotic leukemia .o 40 to 599 1 to 560     Submitted on the opposite strand 560/560
(100 %)
3 diff
(99.5 %id)
AL706160 human skeletal muscle .o 204 to 955 1 to 753       753/753
(100 %)
5 diff
(99.4 %id)
CD655950 Embryonic Stem cells .o 391 to 1177 12 to 791   tiling clone,   780/805
(96 %)
13 diff
(98.4 %id)
DW428600 Liver .o 449 to 705 17 to 275       259/275
(94 %)
6 diff
(97.9 %id)
AL698830 human skeletal muscle .o 739 to 1048 1 to 312       312/312
(100 %)
5 diff
(98.4 %id)
CN285591 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .o 1247 to 1574 1 to 328       328/328
(100 %)
4 diff
(98.8 %id)
BF830783 head_neck .o 1261 to 1511 256 to 7   tiling clone, Submitted on the opposite strand 250/256
(97 %)
0 diff
(100 %id)
CN294849 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .o 1262 to 1653 1 to 392       392/392
(100 %)
6 diff
(98.5 %id)
FN168633 breast carcinoma .o 1316 to 1392 1 to 77       77/77
(100 %)
1 diff
(98.8 %id)
FN166066 breast carcinoma .o 1600 to 1667 1 to 68       68/68
(100 %)
1 diff
(98.6 %id)
BX507209 Liver .o 1639 to 2190 1 to 552       552/552
(100 %)
1 diff
(99.9 %id)
AL600440   .o 1738 to 2232 6 to 499       494/499
(98 %)
6 diff
(98.8 %id)
CN482633 eye .o 1997 to 2480 1 to 484       484/484
(100 %)
0 diff
(100 %id)
AW844994 colon .o 2010 to 2334 326 to 2       325/326
(99 %)
0 diff
(100 %id)
AU311616 neuroblastoma .o 2821 to 3394 1 to 574       574/574
(100 %)
0 diff
(100 %id)
AI081577 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .o 2941 to 3422 482 to 1       482/482
(100 %)
0 diff
(100 %id)
AI288583 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .o 3016 to 3422 407 to 1       407/407
(100 %)
1 diff
(99.8 %id)
BE769077 prostate_tumor .o 3022 to 3276 18 to 270       253/270
(93 %)
6 diff
(97.8 %id)
BE769073 prostate_tumor .o 3026 to 3265 249 to 9       241/249
(96 %)
0 diff
(100 %id)
AL598745   .o 3082 to 3480 1 to 399       399/404
(98 %)
1 diff
(99.8 %id)
BG012835 placenta_normal .o 3181 to 3400 225 to 3       223/247
(90 %)
19 diff
(92.4 %id)
BG927670 cartilage .o 3217 to 3677 90 to 549       460/484
(95 %)
10 diff
(98.0 %id)
BQ884283 sciatic nerve .o 4237 to 5004 1 to 778       778/868
(89 %)
21 diff
(97.6 %id)
BX645791   .o 4383 to 4885 1 to 503       503/503
(100 %)
1 diff
(99.9 %id)
DB277176 uterus .o 4493 to 5039 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
BF373555 prostate_tumor .o 4543 to 4875 339 to 1       339/339
(100 %)
24 diff
(93.0 %id)
DB009086 colon, tumor tissue .o 4569 to 5124 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
BQ371962 prostate_normal .o 4737 to 5291 14 to 569       556/574
(96 %)
19 diff
(96.7 %id)
CV351384 prostate_normal .o 4737 to 4943 16 to 223       208/223
(93 %)
6 diff
(97.4 %id)
CV351430 prostate_normal .o 4745 to 5290 552 to 8     Submitted on the opposite strand 545/552
(98 %)
0 diff
(100 %id)
TI_44459168   .o 4760 to 5684 56 to 983       928/986
(94 %)
25 diff
(97.5 %id)
BI518558 leukocyte .o 4770 to 5684 1 to 918       918/921
(99 %)
21 diff
(97.8 %id)
CK429608 eye, lacrimal gland .o 4856 to 5447 1 to 592       592/592
(100 %)
2 diff
(99.7 %id)
BX486370   .o 5146 to 5852 1 to 706       706/706
(100 %)
4 diff
(99.5 %id)
AA013183 eye, retina .o 5459 to 5962 11 to 514     Submitted on the opposite strand 504/510
(98 %)
5 diff
(99.1 %id)
AA021577 eye, retina .o 5459 to 5864 1 to 408     Submitted on the opposite strand 408/408
(100 %)
5 diff
(98.8 %id)
AA057522 eye, retina .o 5459 to 5969 13 to 522     Submitted on the opposite strand 510/516
(98 %)
5 diff
(99.1 %id)
AW817010 stomach .o 5574 to 5726 1 to 154       154/155
(99 %)
6 diff
(96.2 %id)
BQ638149 eye, retina .o 5648 to 6288 1 to 641       641/641
(100 %)
1 diff
(99.9 %id)
T39284 lung .p-u 1 to 255 1 to 255       255/255
(100 %)
0 diff
(100 %id)
T39303 lung .p-u 1 to 269 1 to 269       269/269
(100 %)
1 diff
(99.7 %id)
T39310 lung .p-u 1 to 274 1 to 274       274/274
(100 %)
0 diff
(100 %id)
T39328 lung .p-u 1 to 293 1 to 293   tiling clone,   293/293
(100 %)
0 diff
(100 %id)
GD160964   .p-u 71 to 242 1 to 172   AAA   172/172
(100 %)
6 diff
(96.6 %id)
BQ901048 sympathetic trunk .p-u 223 to 1124 1 to 914   tiling clone,   914/918
(99 %)
21 diff
(97.8 %id)
DB146983 thymus .p-u 276 to 842 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
AW853208 colon .p-u 648 to 1202 569 to 1   tiling clone,   569/574
(99 %)
37 diff
(93.6 %id)
BG925182 cartilage .p-u 923 to 1488 85 to 650   tiling clone,   566/586
(96 %)
1 diff
(99.9 %id)
BG570728 placenta .p-u 1121 to 1943 1 to 816 G24A V34C     816/817
(99 %)
23 diff
(97.2 %id)
BG432335 Kidney .p-u 1366 to 2118 1 to 770 exact     770/774
(99 %)
29 diff
(96.3 %id)
BM083530 Kidney .p-u 1367 to 1991 1 to 628 exact tiling clone,   628/628
(100 %)
3 diff
(99.6 %id)
AA315821 lung .p-u 1601 to 1833 1 to 234 Y6X     234/234
(100 %)
2 diff
(99.2 %id)
BP425048 small intestine .p-u 1801 to 2303 1 to 503   tiling clone, Submitted on the opposite strand 503/503
(100 %)
1 diff
(99.9 %id)
TI_149283344   .p-u 1805 to 2513 711 to 1   tiling clone,   711/713
(99 %)
36 diff
(95.0 %id)
CB854559 lung, Primary Lung Epithelial Cells .p-u 1923 to 2335 413 to 1       413/414
(99 %)
4 diff
(99.1 %id)
T40507 lung .p-u 2174 to 2500 327 to 2       326/331
(98 %)
0 diff
(100 %id)
T40519 lung .p-u 2255 to 2516 261 to 1   tiling clone,   261/261
(100 %)
4 diff
(98.5 %id)
DA372104 thalamus .q 1 to 551 2 to 552   tiling clone, capped   551/551
(100 %)
1 diff
(99.9 %id)
CU449042 epidermis .q 551 to 1219 668 to 1 F9S H89Y N105Y R107S L108S ... tiling clone, Submitted on the opposite strand 668/682
(97 %)
12 diff
(98.3 %id)
BX504772   .r-u 1 to 608 1 to 608 exact tiling clone,   608/608
(100 %)
1 diff
(99.9 %id)
BF357333 head_neck .r-u 240 to 530 291 to 1       291/293
(99 %)
10 diff
(96.6 %id)
BF357343 head_neck .r-u 240 to 457 218 to 1       218/220
(99 %)
12 diff
(94.6 %id)
BF831660 head_neck .r-u 264 to 576 1 to 309       309/312
(99 %)
21 diff
(93.3 %id)
FN096287 breast carcinoma .r-u 459 to 549 1 to 89       89/91
(97 %)
4 diff
(95.7 %id)
CB270246 adipose .r-u 582 to 997 1 to 415   tiling clone,   415/415
(100 %)
2 diff
(99.6 %id)
DB051401 testis .s 1 to 563 2 to 564   tiling clone, capped   563/563
(100 %)
1 diff
(99.9 %id)
R81040 placenta .s 466 to 892 440 to 1 V5S E7R A9S Q10T L11T ... tiling clone, Submitted on the opposite strand 440/444
(99 %)
21 diff
(95.3 %id)
BF740038 Kidney .t 1 to 524 1 to 524 exact   Submitted on the opposite strand 524/524
(100 %)
1 diff
(99.9 %id)
TI_154132354   .t 1 to 699 61 to 759 exact tiling clone, Submitted on the opposite strand 699/764
(91 %)
19 diff
(97.6 %id)
AW574939 lymph .t 2 to 549 1 to 548 exact   Submitted on the opposite strand 548/548
(100 %)
0 diff
(100 %id)
AW468809 pooled .t 19 to 483 1 to 465 exact   Submitted on the opposite strand 465/465
(100 %)
2 diff
(99.6 %id)
BF110099 carcinoid, lung .t 43 to 484 1 to 442 exact   Submitted on the opposite strand 442/442
(100 %)
5 diff
(98.9 %id)
AA960783 pooled .t 54 to 419 1 to 366 exact   Submitted on the opposite strand 366/366
(100 %)
0 diff
(100 %id)
BM010110 amelanotic melanoma, cell line, skin .t 137 to 808 1 to 673 exact AAA   673/688
(97 %)
5 diff
(99.3 %id)
TI_59384907   .t 138 to 808 100 to 771 exact     672/874
(76 %)
4 diff
(99.6 %id)
AW367133 head_neck .t 283 to 546 285 to 21       265/285
(92 %)
3 diff
(99.0 %id)
TI_154141133   .t 373 to 811 539 to 100   tiling clone, AAA Submitted on the opposite strand 440/468
(94 %)
7 diff
(98.6 %id)
AI583206 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .t 377 to 809 443 to 11   AAA   433/433
(100 %)
0 diff
(100 %id)
AI026736   .t 395 to 810 418 to 3       416/418
(99 %)
0 diff
(100 %id)
AI271708 Kidney .t 436 to 810 377 to 3       375/377
(99 %)
0 diff
(100 %id)
AW404233 lymph .t 445 to 811 394 to 28   AAA Submitted on the opposite strand 367/367
(100 %)
0 diff
(100 %id)
AL706277 human skeletal muscle .u-u 1 to 751 1 to 753 P57X tiling clone,   753/753
(100 %)
5 diff
(99.4 %id)
DB132290 thymus .va-u 1 to 536 2 to 537 exact tiling clone, capped   536/536
(100 %)
0 diff
(100 %id)
320 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p-u, .q, .r-u, .s, .t, .u-u, .va-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI